Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

AstraZeneca develops new class of MMP inhibitors with selectivity for MMP-13, MMP-9

April 7, 2000

British Biotech designs more MMP-inhibitory hydroxamic acid derivatives

April 6, 2000

Another indication for Enbrel will be discussed at advisory committee meeting

April 5, 2000

Scios compounds useful for conditions characterized by excess p38alpha or TGF-beta activity

April 5, 2000

Aventis launches Arava in Canada for treatment of rheumatoid arthritis

April 5, 2000

Japan Energy describes preparation and use of cPLA2 inhibitors

April 4, 2000

COX-2-inhibitory indole compounds synthesized by Pfizer

April 3, 2000

Diarylbenzopyran derivatives designed at Pacific for inflammation, pain and fever

March 31, 2000

Pfizer claims NSAIDs linked to NO-releasing moiety associated with reduced GI toxicity

March 30, 2000

New series from SB interacts with signal transduction to inhibit inflammation

March 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...